Search research articles
Contact Us
Filters
Showing results (231-240 of 249) with videos related to
Page
of 25
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience
J Rodriguez, M D Caballero, A Gutierrez, et al.
British Journal of Haematology
|
June 10, 2000
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients
J J Lahuerta, J Martinez-Lopez, J D Serna, et al.
Bone Marrow Transplantation
|
April 2, 2014
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
M Mohty, K Hübel, N Kröger, et al.
Sangre
|
April 1, 1997
[Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma]
J García Laraña, J Díaz Mediavilla, R Martínez, et al.
British Journal of Haematology
|
June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma
J J Lahuerta, J Martinez-Lopez, C Grande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome
M Constans, A Sureda, M J Terol, et al.
Bone Marrow Transplantation
|
September 22, 2019
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
E González-Barca, A Boumendil, D Blaise, et al.
Bone Marrow Transplantation
|
October 29, 2021
A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection
R Parody, I Sánchez-Ortega, A Mussetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2002
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group
M D Caballero, J A Pérez-Simón, A Iriondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group
A Sureda, R Arranz, A Iriondo, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 249) with videos related to
Sort By:
Page
of 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience
J Rodriguez, M D Caballero, A Gutierrez, et al.
British Journal of Haematology
|
June 10, 2000
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients
J J Lahuerta, J Martinez-Lopez, J D Serna, et al.
Bone Marrow Transplantation
|
April 2, 2014
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
M Mohty, K Hübel, N Kröger, et al.
Sangre
|
April 1, 1997
[Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma]
J García Laraña, J Díaz Mediavilla, R Martínez, et al.
British Journal of Haematology
|
June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma
J J Lahuerta, J Martinez-Lopez, C Grande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome
M Constans, A Sureda, M J Terol, et al.
Bone Marrow Transplantation
|
September 22, 2019
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
E González-Barca, A Boumendil, D Blaise, et al.
Bone Marrow Transplantation
|
October 29, 2021
A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection
R Parody, I Sánchez-Ortega, A Mussetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2002
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group
M D Caballero, J A Pérez-Simón, A Iriondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group
A Sureda, R Arranz, A Iriondo, et al.
Page
of 25